revenue was 36.6% while the increased rate of cost was 45.0% compared with Q1–2019 and also the increased rate in revenue was 68.0% while the increased rate of cost was 75.4% compared with Q2–2018, the

comparison million or net profit o Summary The Operatin venues : Revenues from services Other income Total rev penses : Cost of sales an Administrative expenses Total ex are of profit o associated com nance

quarter of 2019 Second quarter of 2018 Increased (Decreased) Amount % 1.1 Revenues from construction Baht 1,353.08 million Baht 2,199.81 million Baht 846.73 million (38.49) 1.2 Cost of construction 102.44

performance and profitability for the year 2020 are as follows: Cost to revenue from transmission and telecommunication tower ratio decreased by 52.31% YoY resulting from decreasing in revenue and

, 2018 with details as follow; unit: million baht Items 6-month period ended 2017 6-month period ended 2018 changes Amount % Amount % Amount % Revenue from sales of goods . . . . . . Cost of sales of goods

, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to

or 27.27 percent decreased by following details;  Cost of goods sold as amount of 282.16 Million Baht as 99.25 Million Baht decreased or 26.02 percent when compared to same period of previous year of

Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76

equipment for lease 80.9 80.6 55.2 0.3 0.4 25.7 46.6 Cost of sales and service 1,348.2 953.9 1,366.0 394.3 41.3 (17.8) (1.3) Cost of equipment for lease 44.2 42.6 31.3 1.6 3.8 12.9 41.2 Administrative

to achieve COD as scheduled in PPA, and construction cost is in line with the budget approved by lenders. This achievement would enable us to keep record of managing the project to commence COD in time